Jasdeepa Nagi, M.D.
Dr. Jasdeepa Nagi is a board-certified hematologist and medical oncologist with extensive experience in clinical care and oncology research. She currently practices with Sutter Medical Group in Sacramento, California, where she has served as a clinical trials investigator since 2019.
Dr. Nagi completed her fellowship in Hematology/Oncology at Providence Hospital and Medical Centers and the Karmanos Cancer Center at Wayne State University, following her residency in Internal Medicine at Wayne State University. She earned her medical degree from Government Medical College in Amritsar, India.
Prior to joining Sutter, Dr. Nagi practiced at Kaiser Permanente and Epic Care Partners in Cancer Care, gaining broad experience in community oncology settings.
In addition to her clinical work, she has held leadership roles in oncology clinical trials and care pathway development, including serving on steering committees and leading lung cancer-focused initiatives.
Dr. Nagi is an active member of professional organizations including the American Society of Clinical Oncology, the American Society of Hematology, and the International Association for the Study of Lung Cancer. She has contributed to multiple presentations and publications, with a particular focus on lung cancer and immunotherapy.
Clinical trials
- Clinical trial
Adjuvant Non-Small-Cell Lung Cancer C5851005 PADL1NK-005
PADL1NK-005: A Randomized, Phase 3, Open-Label Study to Evaluate PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Status: Open to Enrollment




